Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy? Stanisław SzalaIwona MitrusAleksander Sochanik Review 16 June 2010 Pages: 1449 - 1455
Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients Kazuko UnoKiyotaka OkunoJunji Hamuro Original Article 01 June 2010 Pages: 1457 - 1465
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer Lee M. KrugTao DaoDavid A. Scheinberg Original Article 08 June 2010 Pages: 1467 - 1479
Identification and characterization of Ch806 mimotopes Lin YangHua JiangZonghai Li Original Article 11 June 2010 Pages: 1481 - 1487
Response definition criteria for ELISPOT assays revisited Z. MoodieL. PriceCedrik M. Britten Original Article Open access 15 June 2010 Pages: 1489 - 1501
The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer Kouichi KobayashiYuriko TanakaYoshitaka Okamoto Original Article 27 June 2010 Pages: 1503 - 1509
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study Shimon SlavinAliza AckersteinShoshana Morecki Original Article 20 June 2010 Pages: 1511 - 1519
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors Jaafar BennounaVincent LevyFabien Calvo Original Article 19 June 2010 Pages: 1521 - 1530
A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer Yuki MasudaKoichi ItoHiroaki Nanba Original Article 20 June 2010 Pages: 1531 - 1541
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection Noriyuki YamadaSatoshi OizumiMasaharu Nishimura Original Article 22 June 2010 Pages: 1543 - 1549
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion Stephanie L. GoffLaura A. JohnsonSteven A. Feldman Original Article 14 July 2010 Pages: 1551 - 1560
CD8+ T cell recognition of polymorphic wild-type sequence p5365–73 peptides in squamous cell carcinoma of the head and neck Pedro A. Andrade FilhoDaisuke ItoRobert L. Ferris Original Article 25 June 2010 Pages: 1561 - 1568
Ninth international conference on progress in vaccination against cancer (PIVAC 9), 8–10 October 2009, Sofia, Bulgaria Elissaveta NaumovaStéphanie McArdleGraham Pawelec Meeting Report 10 March 2010 Pages: 1569 - 1572
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy Gerty SchreibeltJurjen TelI. Jolanda M. de Vries Focussed Research Review 05 March 2010 Pages: 1573 - 1582
DNA vaccination strategies for anti-tumour effective gene therapy protocols Emanuela SignoriSandra IuresciaVito Michele Fazio Focussed Research Review 14 April 2010 Pages: 1583 - 1591
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity Suzanne Ostrand-Rosenberg Focussed Research Review 23 April 2010 Pages: 1593 - 1600
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions Federico GarridoIgnacio AlgarraAngel M. García-Lora Focussed Research Review 13 July 2010 Pages: 1601 - 1606
Cetuximab-dependent ADCC in cancer: dream or reality? Alessandro OttaianoStefania ScalaVincenzo Rosario Iaffaioli Letter to the editor 25 June 2010 Pages: 1607 - 1608
Response to the letter to the editors by Ottaiano et al.: “Cetuximab-dependent ADCC in cancer: dream or reality?” Robert L. FerrisSoldano Ferrone Letter to the editor 30 June 2010 Pages: 1609 - 1610
